APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cryogenic Biobanking Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cryogenic Biobanking Services Market Outlook and Growth Opportunities 2026

4 January 2026194 pages

Choose your research edition.

Industry ResearchCryogenic Biobanking Services Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Cryogenic Biobanking Services Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Cryogenic Biobanking Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cryogenic Biobanking Services Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Cryogenic Biobanking Services Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Cryogenic Biobanking Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cryogenic Biobanking Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cryogenic Biobanking Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cryogenic Biobanking Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cryogenic Biobanking Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cryogenic Biobanking Services market include BioKryo, Cryotherm, Thermo Fisher Scientific, Cryoniss, Haier Biomedical, Cryo Bio System, INNOVACORE, CyteTech and Consarctic, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cryogenic Biobanking Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cryogenic Biobanking Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cryogenic Biobanking Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cryogenic Biobanking Services market.

Cryogenic Biobanking Services Segment by Company

BioKryo

Cryotherm

Thermo Fisher Scientific

Cryoniss

Haier Biomedical

Cryo Bio System

INNOVACORE

CyteTech

Consarctic

Clinigen

Cryogenic Biobanking Services Segment by Type

Ice Machines

Freezers

Alarms And Monitoring System

Refrigerators

Cryogenic Storage Systems

Accessories

Cryogenic Biobanking Services Segment by Application

Biobaking

Regenerative Medicine

Drug Discovery

Cryogenic Biobanking Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cryogenic Biobanking Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cryogenic Biobanking Services key companies, revenue, market share, and recent developments.

3. To split the Cryogenic Biobanking Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cryogenic Biobanking Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cryogenic Biobanking Services significant trends, drivers, influence factors in global and regions.

6. To analyze Cryogenic Biobanking Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cryogenic Biobanking Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cryogenic Biobanking Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cryogenic Biobanking Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cryogenic Biobanking Services industry.

Chapter 3: Detailed analysis of Cryogenic Biobanking Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cryogenic Biobanking Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cryogenic Biobanking Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cryogenic Biobanking Services Industry Trends Table 2. Cryogenic Biobanking Services Industry Drivers Table 3. Cryogenic Biobanking Services Industry Opportunities and Challenges Table 4. Cryogenic Biobanking Services Industry Restraints Table 5. Global Cryogenic Biobanking Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cryogenic Biobanking Services Revenue Share by Company (2021-2026) Table 7. Global Cryogenic Biobanking Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cryogenic Biobanking Services Key Company Manufacturing Base & Headquarters Table 9. Global Cryogenic Biobanking Services Company, Product Type & Application Table 10. Global Cryogenic Biobanking Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cryogenic Biobanking Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Ice Machines Table 15. Significant Companies of Freezers Table 16. Significant Companies of Alarms And Monitoring System Table 17. Significant Companies of Refrigerators Table 18. Significant Companies of Cryogenic Storage Systems Table 19. Significant Companies of Accessories Table 20. Global Cryogenic Biobanking Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Cryogenic Biobanking Services Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Cryogenic Biobanking Services Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Cryogenic Biobanking Services Sales Value Share by Type (2021-2026) Table 24. Global Cryogenic Biobanking Services Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Biobaking Table 26. Significant Companies of Regenerative Medicine Table 27. Significant Companies of Drug Discovery Table 28. Global Cryogenic Biobanking Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Cryogenic Biobanking Services Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Cryogenic Biobanking Services Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Cryogenic Biobanking Services Sales Value Share by Application (2021-2026) Table 32. Global Cryogenic Biobanking Services Sales Value Share by Application (2027-2032) Table 33. Global Cryogenic Biobanking Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Cryogenic Biobanking Services Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Cryogenic Biobanking Services Sales Value Share by Region (2021-2026) Table 36. Global Cryogenic Biobanking Services Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Cryogenic Biobanking Services Sales Value Share by Region (2027-2032) Table 38. Global Cryogenic Biobanking Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Cryogenic Biobanking Services Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Cryogenic Biobanking Services Sales Value Market Share by Country (2021-2026) Table 41. Global Cryogenic Biobanking Services Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Cryogenic Biobanking Services Sales Value Market Share by Country (2027-2032) Table 43. BioKryo Company Information Table 44. BioKryo Business Overview Table 45. BioKryo Cryogenic Biobanking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. BioKryo Cryogenic Biobanking Services Product Portfolio Table 47. BioKryo Recent Development Table 48. Cryotherm Company Information Table 49. Cryotherm Business Overview Table 50. Cryotherm Cryogenic Biobanking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Cryotherm Cryogenic Biobanking Services Product Portfolio Table 52. Cryotherm Recent Development Table 53. Thermo Fisher Scientific Company Information Table 54. Thermo Fisher Scientific Business Overview Table 55. Thermo Fisher Scientific Cryogenic Biobanking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Thermo Fisher Scientific Cryogenic Biobanking Services Product Portfolio Table 57. Thermo Fisher Scientific Recent Development Table 58. Cryoniss Company Information Table 59. Cryoniss Business Overview Table 60. Cryoniss Cryogenic Biobanking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Cryoniss Cryogenic Biobanking Services Product Portfolio Table 62. Cryoniss Recent Development Table 63. Haier Biomedical Company Information Table 64. Haier Biomedical Business Overview Table 65. Haier Biomedical Cryogenic Biobanking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Haier Biomedical Cryogenic Biobanking Services Product Portfolio Table 67. Haier Biomedical Recent Development Table 68. Cryo Bio System Company Information Table 69. Cryo Bio System Business Overview Table 70. Cryo Bio System Cryogenic Biobanking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Cryo Bio System Cryogenic Biobanking Services Product Portfolio Table 72. Cryo Bio System Recent Development Table 73. INNOVACORE Company Information Table 74. INNOVACORE Business Overview Table 75. INNOVACORE Cryogenic Biobanking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. INNOVACORE Cryogenic Biobanking Services Product Portfolio Table 77. INNOVACORE Recent Development Table 78. CyteTech Company Information Table 79. CyteTech Business Overview Table 80. CyteTech Cryogenic Biobanking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. CyteTech Cryogenic Biobanking Services Product Portfolio Table 82. CyteTech Recent Development Table 83. Consarctic Company Information Table 84. Consarctic Business Overview Table 85. Consarctic Cryogenic Biobanking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Consarctic Cryogenic Biobanking Services Product Portfolio Table 87. Consarctic Recent Development Table 88. Clinigen Company Information Table 89. Clinigen Business Overview Table 90. Clinigen Cryogenic Biobanking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Clinigen Cryogenic Biobanking Services Product Portfolio Table 92. Clinigen Recent Development Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Cryogenic Biobanking Services Product Image Figure 2. Global Cryogenic Biobanking Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cryogenic Biobanking Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Cryogenic Biobanking Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Ice Machines Image Figure 8. Freezers Image Figure 9. Alarms And Monitoring System Image Figure 10. Refrigerators Image Figure 11. Cryogenic Storage Systems Image Figure 12. Accessories Image Figure 13. Global Cryogenic Biobanking Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Cryogenic Biobanking Services Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Cryogenic Biobanking Services Sales Value Share by Type (2021-2032) Figure 16. Biobaking Image Figure 17. Regenerative Medicine Image Figure 18. Drug Discovery Image Figure 19. Global Cryogenic Biobanking Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Cryogenic Biobanking Services Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Cryogenic Biobanking Services Sales Value Share by Application (2021-2032) Figure 22. Global Cryogenic Biobanking Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Cryogenic Biobanking Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Cryogenic Biobanking Services Sales Value (2021-2032) & (US$ Million) Figure 25. North America Cryogenic Biobanking Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Cryogenic Biobanking Services Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Cryogenic Biobanking Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Cryogenic Biobanking Services Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Cryogenic Biobanking Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Cryogenic Biobanking Services Sales Value (2021-2032) & (US$ Million) Figure 31. South America Cryogenic Biobanking Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Cryogenic Biobanking Services Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Cryogenic Biobanking Services Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Ice Machines
  • Freezers
  • Alarms And Monitoring System
  • Refrigerators
  • Cryogenic Storage Systems
  • Accessories
Applications
  • Biobaking
  • Regenerative Medicine
  • Drug Discovery
Companies covered
  • BioKryo
  • Cryotherm
  • Thermo Fisher Scientific
  • Cryoniss
  • Haier Biomedical
  • Cryo Bio System
  • INNOVACORE
  • CyteTech
  • Consarctic
  • Clinigen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cryogenic Biobanking Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cryogenic Biobanking Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cryogenic Biobanking Services Market Dynamics
  1. 2.1 Cryogenic Biobanking Services Industry Trends
  2. 2.2 Cryogenic Biobanking Services Industry Drivers
  3. 2.3 Cryogenic Biobanking Services Industry Opportunities and Challenges
  4. 2.4 Cryogenic Biobanking Services Industry Restraints
3 Cryogenic Biobanking Services Market by Company
  1. 3.1 Global Cryogenic Biobanking Services Company Revenue Ranking in 2025
  2. 3.2 Global Cryogenic Biobanking Services Revenue by Company (2021-2026)
  3. 3.3 Global Cryogenic Biobanking Services Company Ranking (2024-2026)
  4. 3.4 Global Cryogenic Biobanking Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Cryogenic Biobanking Services Company Product Type and Application
  6. 3.6 Global Cryogenic Biobanking Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cryogenic Biobanking Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cryogenic Biobanking Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cryogenic Biobanking Services Market by Type
  1. 4.1 Cryogenic Biobanking Services Type Introduction
  2. 4.1.1 Ice Machines
  3. 4.1.2 Freezers
  4. 4.1.3 Alarms And Monitoring System
  5. 4.1.4 Refrigerators
  6. 4.1.5 Cryogenic Storage Systems
  7. 4.1.6 Accessories
  8. 4.2 Global Cryogenic Biobanking Services Sales Value by Type
  9. 4.2.1 Global Cryogenic Biobanking Services Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Cryogenic Biobanking Services Sales Value by Type (2021-2032)
  11. 4.2.3 Global Cryogenic Biobanking Services Sales Value Share by Type (2021-2032)
5 Cryogenic Biobanking Services Market by Application
  1. 5.1 Cryogenic Biobanking Services Application Introduction
  2. 5.1.1 Biobaking
  3. 5.1.2 Regenerative Medicine
  4. 5.1.3 Drug Discovery
  5. 5.2 Global Cryogenic Biobanking Services Sales Value by Application
  6. 5.2.1 Global Cryogenic Biobanking Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cryogenic Biobanking Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global Cryogenic Biobanking Services Sales Value Share by Application (2021-2032)
6 Cryogenic Biobanking Services Regional Value Analysis
  1. 6.1 Global Cryogenic Biobanking Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cryogenic Biobanking Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cryogenic Biobanking Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cryogenic Biobanking Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cryogenic Biobanking Services Sales Value (2021-2032)
  7. 6.3.2 North America Cryogenic Biobanking Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cryogenic Biobanking Services Sales Value (2021-2032)
  10. 6.4.2 Europe Cryogenic Biobanking Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cryogenic Biobanking Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cryogenic Biobanking Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cryogenic Biobanking Services Sales Value (2021-2032)
  16. 6.6.2 South America Cryogenic Biobanking Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cryogenic Biobanking Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cryogenic Biobanking Services Sales Value Share by Country, 2025 VS 2032
7 Cryogenic Biobanking Services Country-level Value Analysis
  1. 7.1 Global Cryogenic Biobanking Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cryogenic Biobanking Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cryogenic Biobanking Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cryogenic Biobanking Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cryogenic Biobanking Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cryogenic Biobanking Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cryogenic Biobanking Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BioKryo
  2. 8.1.1 BioKryo Company Information
  3. 8.1.2 BioKryo Business Overview
  4. 8.1.3 BioKryo Cryogenic Biobanking Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BioKryo Cryogenic Biobanking Services Product Portfolio
  6. 8.1.5 BioKryo Recent Developments
  7. 8.2 Cryotherm
  8. 8.2.1 Cryotherm Company Information
  9. 8.2.2 Cryotherm Business Overview
  10. 8.2.3 Cryotherm Cryogenic Biobanking Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cryotherm Cryogenic Biobanking Services Product Portfolio
  12. 8.2.5 Cryotherm Recent Developments
  13. 8.3 Thermo Fisher Scientific
  14. 8.3.1 Thermo Fisher Scientific Company Information
  15. 8.3.2 Thermo Fisher Scientific Business Overview
  16. 8.3.3 Thermo Fisher Scientific Cryogenic Biobanking Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Thermo Fisher Scientific Cryogenic Biobanking Services Product Portfolio
  18. 8.3.5 Thermo Fisher Scientific Recent Developments
  19. 8.4 Cryoniss
  20. 8.4.1 Cryoniss Company Information
  21. 8.4.2 Cryoniss Business Overview
  22. 8.4.3 Cryoniss Cryogenic Biobanking Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Cryoniss Cryogenic Biobanking Services Product Portfolio
  24. 8.4.5 Cryoniss Recent Developments
  25. 8.5 Haier Biomedical
  26. 8.5.1 Haier Biomedical Company Information
  27. 8.5.2 Haier Biomedical Business Overview
  28. 8.5.3 Haier Biomedical Cryogenic Biobanking Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Haier Biomedical Cryogenic Biobanking Services Product Portfolio
  30. 8.5.5 Haier Biomedical Recent Developments
  31. 8.6 Cryo Bio System
  32. 8.6.1 Cryo Bio System Company Information
  33. 8.6.2 Cryo Bio System Business Overview
  34. 8.6.3 Cryo Bio System Cryogenic Biobanking Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cryo Bio System Cryogenic Biobanking Services Product Portfolio
  36. 8.6.5 Cryo Bio System Recent Developments
  37. 8.7 INNOVACORE
  38. 8.7.1 INNOVACORE Company Information
  39. 8.7.2 INNOVACORE Business Overview
  40. 8.7.3 INNOVACORE Cryogenic Biobanking Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 INNOVACORE Cryogenic Biobanking Services Product Portfolio
  42. 8.7.5 INNOVACORE Recent Developments
  43. 8.8 CyteTech
  44. 8.8.1 CyteTech Company Information
  45. 8.8.2 CyteTech Business Overview
  46. 8.8.3 CyteTech Cryogenic Biobanking Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CyteTech Cryogenic Biobanking Services Product Portfolio
  48. 8.8.5 CyteTech Recent Developments
  49. 8.9 Consarctic
  50. 8.9.1 Consarctic Company Information
  51. 8.9.2 Consarctic Business Overview
  52. 8.9.3 Consarctic Cryogenic Biobanking Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Consarctic Cryogenic Biobanking Services Product Portfolio
  54. 8.9.5 Consarctic Recent Developments
  55. 8.10 Clinigen
  56. 8.10.1 Clinigen Company Information
  57. 8.10.2 Clinigen Business Overview
  58. 8.10.3 Clinigen Cryogenic Biobanking Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Clinigen Cryogenic Biobanking Services Product Portfolio
  60. 8.10.5 Clinigen Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst